DIA Global Annual Meeting

Stacy Hurt, M.H.A., M.B.A.

Chief Patient Officer

Panelist (patient perspective) | Monday, June 17 at 8 a.m.

Innovation - The Possibilities, the Boundaries - Charting New Horizons

Speaker | Monday, June 17 at 3:30 p.m.

Bedside to Bench: How Lived Experience, Patient-Led Solutions Should Inform Clinical Trial Delivery

Speaker | Tuesday, June 18 at 3:15 p.m​.

Strategies to Make your Clinical Trials More Inclusive for Patients with Disabilities​

Xoli Belgrave

Senior Director, Head of Clinical Trial Diversity and Inclusion

Speaker | Monday, June 17 at 11 a.m​.

From Intention to Action: Building Diversity, Equity, and Inclusion Initiatives to Create a Culture of Belonging

Jenny Denney

Executive Vice President and Head of FSP Clinical and Biometrics

Speaker | Tuesday, June 18 at 2:30 p.m.

FSP Partnership: a foundation for innovation and patient-guided development

The optimal outsourcing model is not a one-size-fits-all approach. FSP outsourcing has dramatically evolved beyond its origins as an efficiency model to better manage the enormous demands of labor in clinical development. FSP is a solution that provides sponsors greater control over data, systems, processes, and resource allocation. Founded on a desire to have more control and flexibility across the portfolio of studies, Pfizer embarked on a plan to transition from predominately full-service outsourcing to a FSP model while in parallel adopting new job roles and responsibilities that place patients and sites at the center of the journey. Join us to learn how Pfizer and Parexel transformed the model creating global resource efficiencies and agility across a portfolio of studies.

Dan Ballard

Senior Vice President, Digital Enablement & Innovation

Panelist | June 17 at 12-2 p.m.

Microsoft Panel/Roundtable
 
Topic: Revolutionizing Life Sciences: The Intersection of AI and Innovation
Diamond Lunch Reception

This 2-hour session is designed to provide insights into how AI can be leveraged to speed data synthesis, increase operational efficiency, and lower cost.  Our experts and your peers will share their knowledge and experiences, providing practical tips and strategies that you can implement in your own organizations.

Jonathan Shough

Chief Information Officer

Panelist | June 20 at 9:15 a.m.

Title – Generative AI-Driven Clinical Trial: A Myth or a Reality?

This session will discuss use of generative AI in the clinical trials lifecycle across use cases such as integration, summarization, translation, content generation, and knowledge extraction.

Jackie Vanderpuye-Orgle, Ph.D.

Vice President, Advanced Analytics

Presenter | June 17 from 12:15-2:15 p.m.

Poster: Artificial Intelligence/Machine Learning advances in Real World Data Analytics

Andrew Marley

Senior Epidemiologist, Epidemiology and Real World Science

Presenter | June 18 from 11:15 - 1:15 p.m.

Poster: EFFECT: An epidemiological framework for equitable representation of racial and ethnic populations in clinical trials

To establish a framework to inform equitable recruitment of underrepresented racial and ethnic populations into sponsored US clinical trials (CTs) in response to the April 2022 draft guidance from the US Food and Drug Administration (FDA).